InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Shenouda Maged. Director active across 2 companies, notably Relmada Therapeutics, INC.. In total, 4 filings have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €75k. History available since 29 January 2024. The latest transaction was disclosed on 16 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations